澳股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BIOTRON LIMITED

0.003

0.000

成交量：52.19万

成交额：1,566.00

市值：398.17万

市盈率：-1.91

高：0.003

开：0.003

低：0.003

收：0.003

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

BIOTRON LIMITED

交易所：

ASX

成立时间：

1999

员工人数：

3

公司地址：

66 Hunter Street,Level 2,Sydney,New South Wales,Australia

官网：

http://www.biotron.com.au

邮编：

2000

电话：

- -

传真：

- -

简介：

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BIT.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","market":"AU","secType":"STK","nameCN":"BIOTRON LIMITED","latestPrice":0.003,"timestamp":1747116720000,"preClose":0.003,"halted":0,"volume":521917,"delay":0,"nameEN":"BIOTRON LIMITED","floatShares":1131782613,"shares":1327245843,"eps":-0.001569,"marketStatus":"已收盘","change":0,"latestTime":"05-13 16:12:00 AEST","open":0.003,"high":0.003,"low":0.003,"amount":1566,"amplitude":0,"askPrice":0.003,"askSize":18311209,"bidPrice":0.002,"bidSize":38426004,"shortable":3,"etf":0,"ttmEps":-0.001569,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1747094400000,1747116000000]],"volumeRatio":1.404504,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","floatShares":1131782613,"roa":"-51.97%","roe":"-121.67%","lyrEps":-0.003809,"volumeRatio":1.404504,"shares":1327245843,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.002,"pbRate":"8.67","psRate":"2.19","week52High":0.058,"institutionHeld":0,"latestPrice":0.003,"committee":0.354526,"eps":-0.001569,"divideRate":0,"volume":521917,"delay":0,"ttmEps":-0.001569,"open":0.003,"prevYearClose":0.016,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.01},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":7658306,"yearFounded":1999,"employeeNum":3,"address":"66 Hunter Street,Level 2,Sydney,New South Wales,Australia","zipCode":"2000"},"stockCompanyDetail":{"websiteUrl":"http://www.biotron.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.5},{"period":"3month","weight":-0.6667},{"period":"6month","weight":-0.8235},{"period":"1year","weight":-0.9375},{"period":"ytd","weight":-0.8125}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.0576},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1466},{"period":"1year","weight":0.1506},{"period":"ytd","weight":0.1051}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.28,"avgChangeRate":-0.06298},{"month":2,"riseRate":0.44,"avgChangeRate":-0.015344},{"month":3,"riseRate":0.24,"avgChangeRate":-0.075071},{"month":4,"riseRate":0.44,"avgChangeRate":0.047428},{"month":5,"riseRate":0.125,"avgChangeRate":-0.140956},{"month":6,"riseRate":0.583333,"avgChangeRate":0.110905},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.016245},{"month":8,"riseRate":0.25,"avgChangeRate":0.059053},{"month":9,"riseRate":0.541667,"avgChangeRate":0.150596},{"month":10,"riseRate":0.333333,"avgChangeRate":0.024497},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.002804},{"month":12,"riseRate":0.458333,"avgChangeRate":0.033506}],"exchange":"ASX","name":"BIOTRON LIMITED","nameEN":"BIOTRON LIMITED"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-03-05","symbol":"BIT.AU","defaultRemindTime":1741129200000,"type":"split","dateTimestamp":1741093200000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":[]}}